Krinsley James S
Division of Critical Care, Stamford Hospital, Stamford, CT 06902, USA.
Hosp Pract (1995). 2011 Apr;39(2):47-55. doi: 10.3810/hp.2011.04.394.
Intensive monitoring of blood glucose concentrations in critically ill patients has become a standard of care in intensive care units over the past 10 years, following the publication of a single-center randomized trial targeting euglycemia in postoperative patients. This article summarizes the literature describing the relationship between hyperglycemia and mortality in the critically ill, the main findings of the major interventional trials of intensive insulin therapy, the association between hypoglycemia and increased glycemic variability with adverse outcomes, and the impact of a preexisting diagnosis of diabetes. A framework for understanding dysglycemia in the critically ill, an approach that recognizes disturbances in the "3 domains" of glycemic control--hyperglycemia, hypoglycemia, and increased glycemic variability--is presented. Finally, practical considerations relating to the implementation of glycemic management protocols are discussed.
在一项针对术后患者实现正常血糖水平的单中心随机试验发表之后,对重症患者的血糖浓度进行强化监测在过去10年里已成为重症监护病房的护理标准。本文总结了描述重症患者高血糖与死亡率之间关系的文献、强化胰岛素治疗主要干预试验的主要发现、低血糖及血糖变异性增加与不良结局之间的关联,以及糖尿病既往诊断的影响。本文还提出了一个理解重症患者血糖异常的框架,该方法认识到血糖控制“三个领域”的紊乱——高血糖、低血糖和血糖变异性增加。最后,讨论了与实施血糖管理方案相关的实际考量。